STOCK TITAN

[Form 4] Portland General Electric Company Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Flora Growth Corp. (FLGC) – Schedule 13D/A Amendment No. 6

CEO and director Clifford Starke reports beneficial ownership of 3,850,886 common shares, equal to 17.1 % of FLGC’s outstanding shares as of the event date 05 May 2025. Voting and dispositive power are held solely by Starke, with no shared control reported. The filing states the change stems from an increase in the issuer’s outstanding share count; no new share purchases or sales by Starke are disclosed. Source of funds is classified “OO” (other) and no contracts, pledges, or additional arrangements are reported. The amendment updates ownership data but does not signal any immediate corporate action beyond reflecting dilution caused by the expanded share base.

Flora Growth Corp. (FLGC) – Emendamento No. 6 al Modulo 13D/A

Il CEO e direttore Clifford Starke comunica una posizione beneficiaria di 3.850.886 azioni ordinarie, pari al 17,1% delle azioni in circolazione di FLGC alla data dell'evento del 5 maggio 2025. Il potere di voto e dispositivi è detenuto esclusivamente da Starke, senza alcun controllo condiviso segnalato. La comunicazione indica che la variazione deriva da un aumento del numero totale di azioni in circolazione; non sono state effettuate nuove acquisizioni o vendite di azioni da parte di Starke. La fonte dei fondi è classificata come “OO” (altro) e non sono riportati contratti, pegni o accordi aggiuntivi. L'emendamento aggiorna i dati di proprietà senza indicare azioni societarie immediate, riflettendo semplicemente la diluizione causata dall'aumento del capitale azionario.

Flora Growth Corp. (FLGC) – Enmienda No. 6 al Formulario 13D/A

El CEO y director Clifford Starke informa una posesión beneficiaria de 3,850,886 acciones comunes, equivalente al 17.1% de las acciones en circulación de FLGC a la fecha del evento 5 de mayo de 2025. El poder de voto y disposición está en manos exclusivas de Starke, sin control compartido reportado. La presentación indica que el cambio se debe a un aumento en el número total de acciones en circulación; no se revelan compras o ventas nuevas de acciones por parte de Starke. La fuente de fondos se clasifica como “OO” (otros) y no se reportan contratos, garantías ni acuerdos adicionales. La enmienda actualiza los datos de propiedad sin señalar ninguna acción corporativa inmediata, reflejando únicamente la dilución causada por la ampliación de la base accionaria.

Flora Growth Corp. (FLGC) – 스케줄 13D/A 수정안 6호

CEO 겸 이사 클리포드 스타크(Clifford Starke)3,850,886 주의 보통주에 대한 실질 소유권을 보고했으며, 이는 2025년 5월 5일 기준 FLGC 발행 주식의 17.1%에 해당합니다. 의결권과 처분권은 전적으로 스타크가 보유하고 있으며, 공동 통제는 보고되지 않았습니다. 제출서류에 따르면 이 변화는 발행 주식 수 증가에서 비롯된 것으로, 스타크의 신규 매수나 매도는 공개되지 않았습니다. 자금 출처는 “OO”(기타)로 분류되며, 계약, 담보 설정 또는 추가 약정은 보고되지 않았습니다. 이번 수정안은 소유권 정보를 갱신한 것으로, 확장된 주식 기반으로 인한 희석 효과를 반영했을 뿐 즉각적인 회사 조치는 나타내지 않습니다.

Flora Growth Corp. (FLGC) – Amendement n° 6 au Schedule 13D/A

Le PDG et administrateur Clifford Starke déclare une possession bénéficiaire de 3 850 886 actions ordinaires, soit 17,1 % des actions en circulation de FLGC à la date de l'événement du 5 mai 2025. Le pouvoir de vote et de disposition est détenu uniquement par Starke, sans contrôle partagé signalé. Le dépôt indique que ce changement résulte d'une augmentation du nombre d'actions en circulation ; aucun nouvel achat ou vente d'actions par Starke n'est divulgué. La source des fonds est classée « OO » (autre) et aucun contrat, nantissement ou accord supplémentaire n'est signalé. L'amendement met à jour les données de propriété sans indiquer d'action immédiate de la société, reflétant simplement la dilution causée par l'élargissement de la base d'actions.

Flora Growth Corp. (FLGC) – Änderung Nr. 6 zum Formular 13D/A

CEO und Direktor Clifford Starke meldet wirtschaftliches Eigentum an 3.850.886 Stammaktien, was 17,1 % der ausstehenden FLGC-Aktien zum Ereignisdatum 5. Mai 2025 entspricht. Starke hält alleinige Stimm- und Verfügungsgewalt, eine gemeinsame Kontrolle wird nicht angegeben. Die Meldung gibt an, dass die Änderung auf eine Erhöhung der ausstehenden Aktienanzahl zurückzuführen ist; keine neuen Käufe oder Verkäufe von Starke werden offenbart. Die Mittelherkunft ist als „OO“ (sonstige) klassifiziert, und es werden keine Verträge, Verpfändungen oder zusätzlichen Vereinbarungen berichtet. Die Änderung aktualisiert die Eigentumsdaten, signalisiert jedoch keine unmittelbaren Unternehmensmaßnahmen, sondern spiegelt lediglich die Verwässerung durch die erweiterte Aktienbasis wider.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider still owns 17.1 %; dilution-driven update, no transaction.

The amendment merely recalculates Starke’s relative stake after FLGC issued more shares. Absolute ownership (3.85 M shares) is unchanged, suggesting no fresh insider buying or selling. While continued 17 % insider ownership is governance-positive, the underlying dilution underscores capital-raising or share-based compensation that investors should monitor. Overall market impact is limited because no active transaction or intent to alter control is indicated.

TL;DR: High insider alignment persists; filing neutral on control.

Starke retains sole voting and dispositive power, reinforcing his influence on corporate decisions. No group activity, agreements, or hostile intentions are revealed, so governance posture stays stable. The dilution noted could marginally weaken insider alignment if further issuances continue, but at 17 % Starke remains a key stakeholder. Investors should watch future equity issuance levels and any subsequent amendments.

Flora Growth Corp. (FLGC) – Emendamento No. 6 al Modulo 13D/A

Il CEO e direttore Clifford Starke comunica una posizione beneficiaria di 3.850.886 azioni ordinarie, pari al 17,1% delle azioni in circolazione di FLGC alla data dell'evento del 5 maggio 2025. Il potere di voto e dispositivi è detenuto esclusivamente da Starke, senza alcun controllo condiviso segnalato. La comunicazione indica che la variazione deriva da un aumento del numero totale di azioni in circolazione; non sono state effettuate nuove acquisizioni o vendite di azioni da parte di Starke. La fonte dei fondi è classificata come “OO” (altro) e non sono riportati contratti, pegni o accordi aggiuntivi. L'emendamento aggiorna i dati di proprietà senza indicare azioni societarie immediate, riflettendo semplicemente la diluizione causata dall'aumento del capitale azionario.

Flora Growth Corp. (FLGC) – Enmienda No. 6 al Formulario 13D/A

El CEO y director Clifford Starke informa una posesión beneficiaria de 3,850,886 acciones comunes, equivalente al 17.1% de las acciones en circulación de FLGC a la fecha del evento 5 de mayo de 2025. El poder de voto y disposición está en manos exclusivas de Starke, sin control compartido reportado. La presentación indica que el cambio se debe a un aumento en el número total de acciones en circulación; no se revelan compras o ventas nuevas de acciones por parte de Starke. La fuente de fondos se clasifica como “OO” (otros) y no se reportan contratos, garantías ni acuerdos adicionales. La enmienda actualiza los datos de propiedad sin señalar ninguna acción corporativa inmediata, reflejando únicamente la dilución causada por la ampliación de la base accionaria.

Flora Growth Corp. (FLGC) – 스케줄 13D/A 수정안 6호

CEO 겸 이사 클리포드 스타크(Clifford Starke)3,850,886 주의 보통주에 대한 실질 소유권을 보고했으며, 이는 2025년 5월 5일 기준 FLGC 발행 주식의 17.1%에 해당합니다. 의결권과 처분권은 전적으로 스타크가 보유하고 있으며, 공동 통제는 보고되지 않았습니다. 제출서류에 따르면 이 변화는 발행 주식 수 증가에서 비롯된 것으로, 스타크의 신규 매수나 매도는 공개되지 않았습니다. 자금 출처는 “OO”(기타)로 분류되며, 계약, 담보 설정 또는 추가 약정은 보고되지 않았습니다. 이번 수정안은 소유권 정보를 갱신한 것으로, 확장된 주식 기반으로 인한 희석 효과를 반영했을 뿐 즉각적인 회사 조치는 나타내지 않습니다.

Flora Growth Corp. (FLGC) – Amendement n° 6 au Schedule 13D/A

Le PDG et administrateur Clifford Starke déclare une possession bénéficiaire de 3 850 886 actions ordinaires, soit 17,1 % des actions en circulation de FLGC à la date de l'événement du 5 mai 2025. Le pouvoir de vote et de disposition est détenu uniquement par Starke, sans contrôle partagé signalé. Le dépôt indique que ce changement résulte d'une augmentation du nombre d'actions en circulation ; aucun nouvel achat ou vente d'actions par Starke n'est divulgué. La source des fonds est classée « OO » (autre) et aucun contrat, nantissement ou accord supplémentaire n'est signalé. L'amendement met à jour les données de propriété sans indiquer d'action immédiate de la société, reflétant simplement la dilution causée par l'élargissement de la base d'actions.

Flora Growth Corp. (FLGC) – Änderung Nr. 6 zum Formular 13D/A

CEO und Direktor Clifford Starke meldet wirtschaftliches Eigentum an 3.850.886 Stammaktien, was 17,1 % der ausstehenden FLGC-Aktien zum Ereignisdatum 5. Mai 2025 entspricht. Starke hält alleinige Stimm- und Verfügungsgewalt, eine gemeinsame Kontrolle wird nicht angegeben. Die Meldung gibt an, dass die Änderung auf eine Erhöhung der ausstehenden Aktienanzahl zurückzuführen ist; keine neuen Käufe oder Verkäufe von Starke werden offenbart. Die Mittelherkunft ist als „OO“ (sonstige) klassifiziert, und es werden keine Verträge, Verpfändungen oder zusätzlichen Vereinbarungen berichtet. Die Änderung aktualisiert die Eigentumsdaten, signalisiert jedoch keine unmittelbaren Unternehmensmaßnahmen, sondern spiegelt lediglich die Verwässerung durch die erweiterte Aktienbasis wider.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Millegan Michael

(Last) (First) (Middle)
121 SW SALMON STREET

(Street)
PORTLAND OR 97204

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PORTLAND GENERAL ELECTRIC CO /OR/ [ POR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/18/2025 A 3,873 A $40.02 20,690(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Balance adjusted to reflect dividend reinvestment on previously vested shares.
Remarks:
Kristina Benson Power of Attorney on behalf of Michael Millegan 07/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Portland General

NYSE:POR

POR Rankings

POR Latest News

POR Latest SEC Filings

POR Stock Data

4.51B
108.88M
0.52%
100.74%
3.43%
Utilities - Regulated Electric
Electric Services
Link
United States
PORTLAND